[SCHEDULE 13D/A] Inspirato Incorporated SEC Filing
Stoney Lonesome HF LP, Coghill Capital Management LLC, Drake Helix Holdings, LLC, CDC Financial, Inc., and Clint D. Coghill report beneficial ownership positions in Inspirato Inc. The filing covers Class A common stock and discloses that Stoney Lonesome directly owns 633,271 shares (~5.1% of outstanding shares) and Drake Helix directly owns 36,000 shares (~0.3%), with CDC Financial and Mr. Coghill potentially attributable to a combined 669,271 shares (~5.4%). The aggregate purchase prices disclosed are approximately $3,349,904 for Stoney Lonesome's shares and $121,947 for Drake Helix's shares, acquired with working capital.
The reporting persons state they issued a presentation on September 2, 2025 opposing the proposed merger between Inspirato and Buyerlink, asserting that the merger would harm minority stockholders, that the board’s approval process was flawed, that CEO Payam Zamani would receive a substantial windfall, and that the combined company would create a conglomerate without apparent synergies. Exhibits referenced include a transactions schedule and the presentation.
- Disclosure of exact holdings and percentages (633,271 shares = ~5.1%; combined attribution = ~5.4%), providing clear investor transparency
- Purchase prices disclosed for principal positions: ~$3,349,904 for Stoney Lonesome and ~$121,947 for Drake Helix, indicating material economic commitment
- Formal public presentation filed as Exhibit 99.1 to explain opposition to the proposed merger, increasing transparency of activist views
- Reporting persons publicly assert the proposed merger will cause "immense value destruction" for minority stockholders, a material adverse claim
- Allegation of a flawed board/special committee process in approving the merger, implying governance concerns
- Claim that CEO Payam Zamani would receive a substantial windfall, indicating potential conflict of interest highlighted in the filing
Insights
TL;DR: A shareholder group controlling about 5.4% of ISPO publicly opposes the proposed merger and disclosed open-market purchases totaling ~669k shares.
The filing documents that Stoney Lonesome holds 633,271 shares (~5.1%) and Drake Helix holds 36,000 shares (~0.3%), with combined attribution to CDC Financial and Mr. Coghill of ~5.4%. Purchase consideration figures are provided, indicating open-market acquisition financed with working capital. The reporting persons formally issued a presentation opposing the Inspirato–Buyerlink merger, detailing governance and valuation concerns and attaching that presentation as Exhibit 99.1. For investors, this represents an organized activist stance by holders large enough to merit attention but not a controlling block.
TL;DR: Activist-oriented disclosure highlights alleged board process flaws and executive enrichment tied to the proposed merger.
The Schedule 13D/A supplements Item 3 and Item 4 to state specific objections to the merger process and outcomes, naming alleged minority-stockholder harm and a purported CEO windfall. The filing attaches a public presentation as the vehicle for those claims. Such disclosures typically precede shareholder engagement or solicitation efforts and could prompt further proxy-stage debate or supplemental disclosures from the company or special committee. The filing does not, however, state specific alternative proposals or planned transactions beyond voting opposition.